Annual Operating Profit
$252.84 M
+$346.50 M+369.98%
December 31, 2024
Summary
- As of March 14, 2025, PTGX annual operating income is $252.84 million, with the most recent change of +$346.50 million (+369.98%) on December 31, 2024.
- During the last 3 years, PTGX annual operating profit has risen by +$378.69 million (+300.92%).
- PTGX annual operating profit is now at all-time high.
Performance
PTGX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$126.78 M
+$168.23 M+405.84%
December 31, 2024
Summary
- As of March 14, 2025, PTGX quarterly operating income is $126.78 million, with the most recent change of +$168.23 million (+405.84%) on December 31, 2024.
- Over the past year, PTGX quarterly operating profit has increased by +$168.23 million (+405.84%).
- PTGX quarterly operating profit is now -38.55% below its all-time high of $206.31 million, reached on March 31, 2024.
Performance
PTGX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$252.84 M
+$103.73 M+69.57%
December 31, 2024
Summary
- As of March 14, 2025, PTGX TTM operating income is $252.84 million, with the most recent change of +$103.73 million (+69.57%) on December 31, 2024.
- Over the past year, PTGX TTM operating profit has increased by +$103.73 million (+69.57%).
- PTGX TTM operating profit is now at all-time high.
Performance
PTGX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
PTGX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +370.0% | +405.8% | +69.6% |
| 3 y3 years | +300.9% | +405.8% | +69.6% |
| 5 y5 years | +414.0% | +405.8% | +69.6% |
PTGX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +292.5% | -38.5% | +399.3% | at high | +265.0% |
| 5 y | 5-year | at high | +292.5% | -38.5% | +399.3% | at high | +265.0% |
| alltime | all time | at high | +292.5% | -38.5% | +399.3% | at high | +265.0% |
Protagonist Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $252.84 M(-370.0%) | $126.78 M(-405.8%) | $252.84 M(+69.6%) |
| Sep 2024 | - | -$41.45 M(+6.9%) | $149.11 M(-2.1%) |
| Jun 2024 | - | -$38.79 M(-118.8%) | $152.24 M(+2.4%) |
| Mar 2024 | - | $206.31 M(+795.1%) | $148.68 M(-258.8%) |
| Dec 2023 | -$93.65 M(-28.7%) | $23.05 M(-160.1%) | -$93.65 M(-38.9%) |
| Sep 2023 | - | -$38.33 M(-9.5%) | -$153.22 M(+4.1%) |
| Jun 2023 | - | -$42.35 M(+17.6%) | -$147.19 M(+0.6%) |
| Mar 2023 | - | -$36.02 M(-1.4%) | -$146.28 M(+11.3%) |
| Dec 2022 | -$131.37 M(+4.4%) | -$36.52 M(+13.0%) | -$131.37 M(-0.4%) |
| Sep 2022 | - | -$32.30 M(-22.1%) | -$131.87 M(-1.2%) |
| Jun 2022 | - | -$41.44 M(+96.3%) | -$133.50 M(+8.6%) |
| Mar 2022 | - | -$21.11 M(-43.0%) | -$122.94 M(-2.3%) |
| Dec 2021 | -$125.84 M(+95.1%) | -$37.02 M(+9.1%) | -$125.84 M(+16.9%) |
| Sep 2021 | - | -$33.93 M(+9.9%) | -$107.66 M(+32.1%) |
| Jun 2021 | - | -$30.88 M(+28.6%) | -$81.50 M(+18.4%) |
| Mar 2021 | - | -$24.02 M(+27.6%) | -$68.84 M(+6.7%) |
| Dec 2020 | -$64.52 M(-19.9%) | -$18.83 M(+142.3%) | -$64.52 M(+2.4%) |
| Sep 2020 | - | -$7.77 M(-57.3%) | -$62.98 M(-13.0%) |
| Jun 2020 | - | -$18.22 M(-7.5%) | -$72.38 M(-15.4%) |
| Mar 2020 | - | -$19.70 M(+13.9%) | -$85.57 M(+6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$80.52 M(+90.5%) | -$17.30 M(+0.8%) | -$80.52 M(+2.4%) |
| Sep 2019 | - | -$17.17 M(-45.3%) | -$78.63 M(+11.0%) |
| Jun 2019 | - | -$31.41 M(+114.4%) | -$70.86 M(+45.5%) |
| Mar 2019 | - | -$14.65 M(-5.0%) | -$48.69 M(+15.2%) |
| Dec 2018 | -$42.27 M(+11.5%) | -$15.41 M(+64.1%) | -$42.27 M(+39.2%) |
| Sep 2018 | - | -$9.39 M(+1.6%) | -$30.37 M(+17.0%) |
| Jun 2018 | - | -$9.24 M(+12.3%) | -$25.96 M(-18.5%) |
| Mar 2018 | - | -$8.23 M(+134.2%) | -$31.85 M(-15.9%) |
| Dec 2017 | -$37.90 M(+16.0%) | -$3.51 M(-29.5%) | -$37.90 M(-17.2%) |
| Sep 2017 | - | -$4.98 M(-67.1%) | -$45.78 M(-4.5%) |
| Jun 2017 | - | -$15.13 M(+6.0%) | -$47.94 M(+20.2%) |
| Mar 2017 | - | -$14.27 M(+25.2%) | -$39.90 M(+22.1%) |
| Dec 2016 | -$32.67 M(+120.8%) | -$11.40 M(+59.7%) | -$32.67 M(+24.3%) |
| Sep 2016 | - | -$7.14 M(+0.7%) | -$26.27 M(+13.5%) |
| Jun 2016 | - | -$7.09 M(+0.7%) | -$23.15 M(+20.9%) |
| Mar 2016 | - | -$7.04 M(+40.8%) | -$19.14 M(+29.4%) |
| Dec 2015 | -$14.79 M(+58.8%) | -$5.00 M(+24.4%) | -$14.79 M(+51.1%) |
| Sep 2015 | - | -$4.02 M(+30.4%) | -$9.79 M(+69.7%) |
| Jun 2015 | - | -$3.08 M(+14.7%) | -$5.77 M(+114.7%) |
| Mar 2015 | - | -$2.69 M | -$2.69 M |
| Dec 2014 | -$9.32 M | - | - |
FAQ
- What is Protagonist Therapeutics annual operating income?
- What is the all time high annual operating profit for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual operating profit year-on-year change?
- What is Protagonist Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly operating profit year-on-year change?
- What is Protagonist Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Protagonist Therapeutics?
- What is Protagonist Therapeutics TTM operating profit year-on-year change?
What is Protagonist Therapeutics annual operating income?
The current annual operating profit of PTGX is $252.84 M
What is the all time high annual operating profit for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual operating income is $252.84 M
What is Protagonist Therapeutics annual operating profit year-on-year change?
Over the past year, PTGX annual operating income has changed by +$346.50 M (+369.98%)
What is Protagonist Therapeutics quarterly operating income?
The current quarterly operating profit of PTGX is $126.78 M
What is the all time high quarterly operating profit for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly operating income is $206.31 M
What is Protagonist Therapeutics quarterly operating profit year-on-year change?
Over the past year, PTGX quarterly operating income has changed by +$168.23 M (+405.84%)
What is Protagonist Therapeutics TTM operating income?
The current TTM operating profit of PTGX is $252.84 M
What is the all time high TTM operating profit for Protagonist Therapeutics?
Protagonist Therapeutics all-time high TTM operating income is $252.84 M
What is Protagonist Therapeutics TTM operating profit year-on-year change?
Over the past year, PTGX TTM operating income has changed by +$103.73 M (+69.57%)